Angiotensin converting enzyme insertion/deletion genetic polymorphism: Its impact on renal function in critically ill patients

被引:28
作者
du Cheyron, Damien [1 ,2 ]
Fradin, Sabine [3 ]
Ramakers, Michel [1 ]
Terzi, Nicolas [1 ]
Guillotin, Damien [1 ]
Bouchet, Bruno [1 ]
Daubin, Cedric [1 ]
Charbonneau, Pierre [1 ]
机构
[1] CHU Caen, Serv Reanimat Med, F-14000 Caen, France
[2] CHU Caen, UPRES, EA2128, F-14000 Caen, France
[3] CHU Caen, Biochim Lab, F-14000 Caen, France
关键词
acute renal failure; angiotensin converting enzyme; polymorphism (genetic); intensive care unit;
D O I
10.1097/CCM.0b013e318186a299
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Previous clinical studies have suggested an association between the insertion/deletion (I/D) genetic polymorphism of angiotensin converting enzyme and acute or chronic diseases. We aimed to test the prognostic value of the I-allele, which is associated with lower angiotensin converting enzyme activity, on acute kidney injury. Design: Prospective 6-month noninterventional study. Setting: Intensive care unit of a University Hospital. Patients and Methods: One hundred eighty consecutive admitted white patients for an expected intensive care unit stay > 48 hr. Angiotensin converting enzyme genetic polymorphism was screened for genotype (I/D polymorphism analysis by polymerase chain reaction amplification) and phenotype (measurement of the circulating rate of angiotensin converting enzyme by spectrophotometry). Acute kidney injury was assessed according to Risk, Injury, Failure, Loss, and End-stage Kidney classification. Intervention: None. Results: II, ID, and DO genotype frequencies were 25%, 48%, and 27%, respectively. II and ID genotypes were associated with lower baseline circulating rates of angiotensin converting enzyme (20 +/- 14 and 22 +/- 18 U/L, respectively, vs. 30 +/- 23 U/L for DD genotype; p = 0.04). Repartition of angiotensin converting enzyme genotypes were different in patients with and without acute kidney injury (p < 0.0001), with greater 11 genotype proportion in acute kidney injury patients (42% vs. 13% for those without acute kidney injury). After adjustment on the identified prognostic factors, II genotype was independently associated with increased risk of acute kidney injury (adjusted odds ratio, 6.5; 95% confidence interval, 2.4-17.7; p = 0.0002), then death among patients with acute kidney injury (adjusted odds ratio, 1.7; 95% confidence ratio, 1.1-2.6; p = 0.02). Conclusion: These data confirm the key role of the renin-angiotensin system to maintain glomerular filtration rate, and highlight an association between a genetic factor and susceptibility to and prognosis of acute kidney disease. (Crit Care Med 2008; 36:3178-3183)
引用
收藏
页码:3178 / 3183
页数:6
相关论文
共 36 条
[1]   Current concepts - Normotensive ischemic acute renal failure [J].
Abuelo, J. Gary .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (08) :797-805
[2]   DIAGNOSING VASCULAR CAUSES OF RENAL-FAILURE [J].
ABUELO, JG .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (08) :601-614
[3]   Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group [J].
Bellomo, R ;
Ronco, C ;
Kellum, JA ;
Mehta, RL ;
Palevsky, P .
CRITICAL CARE, 2004, 8 (04) :R204-R212
[4]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[5]   The era of genomics: Impact on sepsis clinical trial design [J].
Cariou, A ;
Chiche, JD ;
Charpentier, J ;
Dhainaut, JF ;
Mira, JP .
CRITICAL CARE MEDICINE, 2002, 30 (05) :S341-S348
[6]   Acute renal failure in the ICU:: risk factors and outcome evaluated by the SOFA score [J].
de Mendonça, A ;
Vincent, JL ;
Suter, PM ;
Moreno, R ;
Dearden, NM ;
Antonelli, M ;
Takala, J ;
Sprung, C ;
Cantraine, F .
INTENSIVE CARE MEDICINE, 2000, 26 (07) :915-921
[7]   Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 (vol 34, pg 17, 2008) [J].
Dellinger, R. Phillip ;
Levy, Mitchell M. ;
Carlet, Jean M. ;
Bion, Julian ;
Parker, Margaret M. ;
Jaeschke, Roman ;
Reinhart, Konrad ;
Angus, Derek C. ;
Brun-Buisson, Christian ;
Beale, Richard ;
Calandra, Thierry ;
Dhainaut, Jean-Francois ;
Gerlach, Herwig ;
Harvey, Maurene ;
Marini, John J. ;
Marshall, John ;
Ranieri, Marco ;
Ramsay, Graham ;
Sevransky, Jonathan ;
Thompson, B. Taylor ;
Townsend, Sean ;
Vender, Jeffrey S. ;
Zimmerman, Janice L. ;
Vincent, Jean-Louis .
INTENSIVE CARE MEDICINE, 2008, 34 (04) :783-785
[8]   Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [J].
Dellinger, RP ;
Carlet, JM ;
Masur, H ;
Gerlach, H ;
Calandra, T ;
Cohen, J ;
Gea-Banacloche, J ;
Keh, D ;
Marshall, JC ;
Parker, MM ;
Ramsay, G ;
Zimmerman, JL ;
Vincent, JL ;
Levy, MM .
CRITICAL CARE MEDICINE, 2004, 32 (03) :858-873
[9]   COSEGREGATION OF BLOOD-PRESSURE WITH ANGIOTENSIN CONVERTING ENZYME AND ATRIAL-NATRIURETIC-PEPTIDE RECEPTOR GENES USING DAHL SALT-SENSITIVE RATS [J].
DENG, YL ;
RAPP, JP .
NATURE GENETICS, 1992, 1 (04) :267-272
[10]   Angiotensin I-converting enzyme genotypes and angiotensin II receptors - Response to therapy [J].
DieguezLucena, JL ;
ArandaLara, P ;
RuizGaldon, M ;
GarciaVillanova, J ;
MorellOcana, M ;
ReyesEngel, A .
HYPERTENSION, 1996, 28 (01) :98-103